BDBM325203 4-((2-(2-isopropylphenyl)-8-oxo-7,8-dihydro-9H-::US10189841, Compound I-409::US10399980, Compound I-409

SMILES: CC(C)c1ccccc1-c1ncc2[nH]c(=O)n(Cc3ccc(cc3)C(=O)NCCN3CCCCC3)c2n1

InChI Key: InChIKey=GLUMOZSAGLAMQX-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 325203   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Ubiquitin carboxyl-terminal hydrolase 1 (Homo sapiens (Human))	BDBM325203 (4-((2-(2-isopropylphenyl)-8-oxo-7,8-dihydro-9H- | ...) Show SMILES CC(C)c1ccccc1-c1ncc2[nH]c(=O)n(Cc3ccc(cc3)C(=O)NCCN3CCCCC3)c2n1 Show InChI InChI=1S/C29H34N6O2/c1-20(2)23-8-4-5-9-24(23)26-31-18-25-27(33-26)35(29(37)32-25)19-21-10-12-22(13-11-21)28(36)30-14-17-34-15-6-3-7-16-34/h4-5,8-13,18,20H,3,6-7,14-17,19H2,1-2H3,(H,30,36)(H,32,37)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
FORMA Therapeutics, Inc. US Patent					Assay Description The HTS assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning...				US Patent US10399980 (2019) BindingDB Entry DOI: 10.7270/Q23J3GCX
					More data for this Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 1 (Homo sapiens (Human))	BDBM325203 (4-((2-(2-isopropylphenyl)-8-oxo-7,8-dihydro-9H- | ...) Show SMILES CC(C)c1ccccc1-c1ncc2[nH]c(=O)n(Cc3ccc(cc3)C(=O)NCCN3CCCCC3)c2n1 Show InChI InChI=1S/C29H34N6O2/c1-20(2)23-8-4-5-9-24(23)26-31-18-25-27(33-26)35(29(37)32-25)19-21-10-12-22(13-11-21)28(36)30-14-17-34-15-6-3-7-16-34/h4-5,8-13,18,20H,3,6-7,14-17,19H2,1-2H3,(H,30,36)(H,32,37)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<0.00200	n/a	n/a	n/a	n/a	n/a	n/a
FORMA Therapeutics, Inc. US Patent					Assay Description The HTS assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning...				US Patent US10189841 (2019) BindingDB Entry DOI: 10.7270/Q22R3TRR
					More data for this Ligand-Target Pair